MK-196: ANTIHYPERTENSIVE

1
r rand d MK-196: ANTIHYPERTENSIVE Equivalent to hydrochlorothiazide A novel indanone diuretic/antihypertensive MK-196 (Merck.. Sharp and Dohme) in a dose of I O-ISmg daily was equivalent to SOmg of hydrochlorothiazide in 42 patients with mild to moderate essential hypertension. This 4-week, multiclinic, double-blind study showed both doses of M K-196 to be associated with fewer side effects (13-15 %) than hydrochlorothiazide (21 %) and to cause less frequent and smaller decreases in serum potassium. Increases of serum uric acid tended to be smaller with MK-196 and it appeared to offer some therapeutic advantages over hydrochlorothiazide. Wilhelmsson. C.E. et al : British Journal or Clinical Pharmacology 8: 261 (Sep 1979) 0156-2703/79/ 1013-0007 $00.50/ 0 © ADIS Press INPHARMA 13 Oct 1979 7

Transcript of MK-196: ANTIHYPERTENSIVE

Page 1: MK-196: ANTIHYPERTENSIVE

r

rand d

MK-196: ANTIHYPERTENSIVE

Equivalent to hydrochlorothiazide A novel indanone diuretic/antihypertensive MK-196 (Merck.. Sharp and Dohme) in a dose of I O-ISmg daily was equivalent to SOmg of hydrochlorothiazide in 42 patients with mild to moderate essential hypertension. This 4-week, multiclinic, double-blind study showed both doses of M K-196 to be associated with fewer side effects (13-15 %) than hydrochlorothiazide (21 %) and to cause less frequent and smaller decreases in serum potassium. Increases of serum uric acid tended to be smaller with MK-196 and it appeared to offer some therapeutic advantages over hydrochlorothiazide. Wilhelmsson. C.E. et al : British Journal or Clinical Pharmacology 8: 261

(Sep 1979)

0156-2703/79/ 1013-0007 $00.50/ 0 © ADIS Press INPHARMA 13 Oct 1979 7